Clinical trial
Clinical Validation Study for Noninvasive Cardiopulmonary Management Device (Phase II)
NCT05445206 is registered in ClinicalTrials.gov with Analog Device, Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Clinical Validation Study for Noninvasive Cardiopulmonary Management Device (Phase II)
- Lead sponsor
- Analog Device, Inc.
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- March 2, 2022
- Completion date
- July 6, 2022
- Enrollment
- 40 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.